The legacy status of Viagra, and the parent firm copyright, presents a complex question for shareholders . While earnings initially surged, the looming patent lapse and increasing generic rivalry https://rorycxto883586.affiliatblogger.com/93923930/copyright-s-blockbuster-and-pharma-a-risky-investment